Marta Czaplicka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marta Czaplicka has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Agnieszka Kamińska
Institute of Physical Chemistry, Polish Academy of Sciences, Warsaw, Poland
4 shared publications - Ariadna B. Nowicka
Faculty of Materials Engineering and Technical Physics, Poznan University of Technology, Piotrowo 3, 60-965 Poznań, Poland
4 shared publications - Tomasz Szymborski
Institute of Physical Chemistry, Polish Academy of Sciences, Kasprzaka 44/52, 01-224 Warsaw, Poland
4 shared publications - Agnieszka Girstun
Department of Molecular Biology, Institute of Biochemistry, Faculty of Biology, University of Warsaw, Ilji Miecznikowa 1, 02-096 Warsaw, Poland
2 shared publications - Aneta Aniela Kowalska
Institute of Physical Chemistry Polish Academy of Sciences Warsaw Poland
2 shared publications - Izabela Chmielewska
Department of Pneumonology, Oncology and Allergology, Medical University of Lublin, Lublin, Poland
2 shared publications
Latest Publications
- Open Access
- 25 August 2022
- Published by MDPI AG in Biosensors
- Vol. 12 (9) , 681
Dielectrophoresis-Based SERS Sensors for the Detection of Cancer Cells in Microfluidic Chips
The detection of freely circulating cancer cells (CTCs) is one of the greatest challenges of modern medical diagnostics. For several years, there has been increased attention on the use of surface-enhanced Raman spectroscopy (SERS) for the detection of CTCs. SERS is a non-destructive, accurate and precise technique, and the use of special SERS platforms even enables the amplification of weak signals from biological objects. In the current study, we demonstrate the unique arrangement of the SERS technique combined with the deposition of CTCs cells on the surface of the SERS platform via a dielectrophoretic effect. The appropriate frequencies of an alternating electric field and a selected shape of the electric field can result in the efficient deposition of CTCs on the SERS platform. The geometry of the microfluidic chip, the type of the cancer cells and the positive dielectrophoretic phenomenon resulted in the trapping of CTCs on the surface of the SERS platform. We presented results for two type of breast cancer cells, MCF-7 and MDA-MB-231, deposited from the 0.1 PBS solution. The limit of detection (LOD) is 20 cells/mL, which reflects the clinical potential and usefulness of the developed approach. We also provide a proof-of-concept for these CTCs deposited on the SERS platform from blood plasma.
- 25 August 2022
- Published by MDPI AG in Biosensors
- Vol. 12 (9) , 681
Open AccessDielectrophoresis-Based SERS Sensors for the Detection of Cancer Cells in Microfluidic Chips
The detection of freely circulating cancer cells (CTCs) is one of the greatest challenges of modern medical diagnostics. For several years, there has been increased attention on the use of surface-enhanced Raman spectroscopy (SERS) for the detection of CTCs. SERS is a non-destructive, accurate and precise technique, and the use of special SERS platforms even enables the amplification of weak signals from biological objects. In the current study, we demonstrate the unique arrangement of the SERS technique combined with the deposition of CTCs cells on the surface of the SERS platform via a dielectrophoretic effect. The appropriate frequencies of an alternating electric field and a selected shape of the electric field can result in the efficient deposition of CTCs on the SERS platform. The geometry of the microfluidic chip, the type of the cancer cells and the positive dielectrophoretic phenomenon resulted in the trapping of CTCs on the surface of the SERS platform. We presented results for two type of breast cancer cells, MCF-7 and MDA-MB-231, deposited from the 0.1 PBS solution. The limit of detection (LOD) is 20 cells/mL, which reflects the clinical potential and usefulness of the developed approach. We also provide a proof-of-concept for these CTCs deposited on the SERS platform from blood plasma.
- Open Access
- 25 April 2022
- Published by MDPI AG in Biomedicines
- Vol. 10 (5) , 993
Lung Cancer: Spectral and Numerical Differentiation among Benign and Malignant Pleural Effusions Based on the Surface-Enhanced Raman Spectroscopy
We present here that the surface-enhanced Raman spectroscopy (SERS) technique in conjunction with the partial least squares analysis is as a potential tool for the differentiation of pleural effusion in the course of the cancerous disease and a tool for faster diagnosis of lung cancer. Pleural effusion occurs mainly in cancer patients due to the spread of the tumor, usually caused by lung cancer. Furthermore, it can also be initiated by non-neoplastic diseases, such as chronic inflammatory infection (the most common reason for histopathological examination of the exudate). The correlation between pleural effusion induced by tumor and non-cancerous diseases were found using surface-enhanced Raman spectroscopy combined with principal component regression (PCR) and partial least squares (PLS) multivariate analysis method. The PCR predicts 96% variance for the division of neoplastic and non-neoplastic samples in 13 principal components while PLS 95% in only 10 factors. Similarly, when analyzing the SERS data to differentiate the type of tumor (squamous cell vs. adenocarcinoma), PLS gives more satisfactory results. This is evidenced by the calculated values of the root mean square errors of calibration and prediction but also the coefficients of calibration determination and prediction (R2C = 0.9570 and R2C = 0.7968), which are more robust and rugged compared to those calculated for PCR. In addition, the relationship between cancerous and non-cancerous samples in the dependence on the gender of the studied patients is presented.
- 25 April 2022
- Published by MDPI AG in Biomedicines
- Vol. 10 (5) , 993
Open AccessLung Cancer: Spectral and Numerical Differentiation among Benign and Malignant Pleural Effusions Based on the Surface-Enhanced Raman Spectroscopy
We present here that the surface-enhanced Raman spectroscopy (SERS) technique in conjunction with the partial least squares analysis is as a potential tool for the differentiation of pleural effusion in the course of the cancerous disease and a tool for faster diagnosis of lung cancer. Pleural effusion occurs mainly in cancer patients due to the spread of the tumor, usually caused by lung cancer. Furthermore, it can also be initiated by non-neoplastic diseases, such as chronic inflammatory infection (the most common reason for histopathological examination of the exudate). The correlation between pleural effusion induced by tumor and non-cancerous diseases were found using surface-enhanced Raman spectroscopy combined with principal component regression (PCR) and partial least squares (PLS) multivariate analysis method. The PCR predicts 96% variance for the division of neoplastic and non-neoplastic samples in 13 principal components while PLS 95% in only 10 factors. Similarly, when analyzing the SERS data to differentiate the type of tumor (squamous cell vs. adenocarcinoma), PLS gives more satisfactory results. This is evidenced by the calculated values of the root mean square errors of calibration and prediction but also the coefficients of calibration determination and prediction (R2C = 0.9570 and R2C = 0.7968), which are more robust and rugged compared to those calculated for PCR. In addition, the relationship between cancerous and non-cancerous samples in the dependence on the gender of the studied patients is presented.
- Open Access
Effect of Varying Expression of EpCAM on the Efficiency of CTCs Detection by SERS-Based Immunomagnetic Optofluidic Device
The circulating tumor cells (CTCs) isolation and characterization has a great potential for non-invasive biopsy. In the present research, the surface–enhanced Raman spectroscopy (SERS)-based assay utilizing magnetic nanoparticles and solid SERS-active support integrated in the external field assisted microfluidic device was designed for efficient isolation of CTCs from blood samples. Magnetic nanospheres (Fe2O3) were coated with SERS-active metal and then modified with p-mercaptobenzoic acid (p-MBA) which works simultaneously as a Raman reporter and linker to an antiepithelial-cell-adhesion-molecule (anti-EpCAM) antibodies. The newly developed laser-induced SERS-active silicon substrate with a very strong enhancement factor (up to 108) and high stability and reproducibility provide the additional extra-enhancement in the sandwich plasmonic configuration of immune assay which finally leads to increase the efficiency of detection. The sensitive immune recognition of cancer cells is assisted by the introducing of the controllable external magnetic field into the microfluidic chip. Moreover, the integration of the SERS-active platform and p-MBA-labeled immuno-Ag@Fe2O3 nanostructures with microfluidic device offers less sample and analytes demand, precise operation, increase reproducibly of spectral responses, and enables miniaturization and portability of the presented approach. In this work, we have also investigated the effect of varying expression of the EpCAM established by the Western Blot method supported by immunochemistry on the efficiency of CTCs’ detection with the developed SERS method. We used four target cancer cell lines with relatively high (human metastatic prostate adenocarcinoma cells (LNCaP)), medium (human metastatic prostate adenocarcinoma cells (LNCaP)), weak (human metastatic prostate adenocarcinoma cells (LNCaP)), and no EpCAM expressions (cervical cancer cells (HeLa)) to estimate the limits of detection based on constructed calibration curves. Finally, blood samples from lung cancer patients were used to validate the efficiency of the developed method in clinical trials.
Open AccessEffect of Varying Expression of EpCAM on the Efficiency of CTCs Detection by SERS-Based Immunomagnetic Optofluidic Device
The circulating tumor cells (CTCs) isolation and characterization has a great potential for non-invasive biopsy. In the present research, the surface–enhanced Raman spectroscopy (SERS)-based assay utilizing magnetic nanoparticles and solid SERS-active support integrated in the external field assisted microfluidic device was designed for efficient isolation of CTCs from blood samples. Magnetic nanospheres (Fe2O3) were coated with SERS-active metal and then modified with p-mercaptobenzoic acid (p-MBA) which works simultaneously as a Raman reporter and linker to an antiepithelial-cell-adhesion-molecule (anti-EpCAM) antibodies. The newly developed laser-induced SERS-active silicon substrate with a very strong enhancement factor (up to 108) and high stability and reproducibility provide the additional extra-enhancement in the sandwich plasmonic configuration of immune assay which finally leads to increase the efficiency of detection. The sensitive immune recognition of cancer cells is assisted by the introducing of the controllable external magnetic field into the microfluidic chip. Moreover, the integration of the SERS-active platform and p-MBA-labeled immuno-Ag@Fe2O3 nanostructures with microfluidic device offers less sample and analytes demand, precise operation, increase reproducibly of spectral responses, and enables miniaturization and portability of the presented approach. In this work, we have also investigated the effect of varying expression of the EpCAM established by the Western Blot method supported by immunochemistry on the efficiency of CTCs’ detection with the developed SERS method. We used four target cancer cell lines with relatively high (human metastatic prostate adenocarcinoma cells (LNCaP)), medium (human metastatic prostate adenocarcinoma cells (LNCaP)), weak (human metastatic prostate adenocarcinoma cells (LNCaP)), and no EpCAM expressions (cervical cancer cells (HeLa)) to estimate the limits of detection based on constructed calibration curves. Finally, blood samples from lung cancer patients were used to validate the efficiency of the developed method in clinical trials.
- Open Access
- 19 September 2019
- Published by MDPI AG in Biosensors
- Vol. 9 (3) , 111
Flexible PET/ITO/Ag SERS Platform for Label-Free Detection of Pesticides
We show a new type of elastic surface-enhanced Raman spectroscopy (SERS) platform made of poly(ethylene terephthalate) (PET) covered with a layer of indium tin oxide (ITO). This composite is subjected to dielectric barrier discharge (DBD) that develops the active surface of the PET/ITO foil. To enhance the Raman signal, a modified composite was covered with a thin layer of silver using the physical vapor deposition (PVD) technique. The SERS platform was used for measurements of para-mercaptobenzoic acid (p-MBA) and popular pesticides, i.e., Thiram and Carbaryl. The detection and identification of pesticides on the surface of fruits and vegetables is a crucial issue due to extensive use of those chemical substances for plant fungicide and insecticide protection. Therefore, the developed PET/ITO/Ag SERS platform was dedicated to quantitative analysis of selected pesticides, i.e., Thiram and Carbaryl from fruits. The presented SERS platform exhibits excellent enhancement and reproducibility of the Raman signal, which enables the trace analysis of these pesticides in the range up to their maximum residues limit. Based on the constructed calibration curves, the pesticide concentrations from the skin of apples was estimated as 2.5 µg/mL and 0.012 µg/mL for Thiram and Carbaryl, respectively. Additionally, the PET/ITO/Ag SERS platform satisfies other spectroscopic properties required for trace pesticide analysis e.g., ease, cost-effective method of preparation, and specially designed physical properties, especially flexibility and transparency, that broaden the sampling versatility to irregular surfaces.
- 19 September 2019
- Published by MDPI AG in Biosensors
- Vol. 9 (3) , 111
Open AccessFlexible PET/ITO/Ag SERS Platform for Label-Free Detection of Pesticides
We show a new type of elastic surface-enhanced Raman spectroscopy (SERS) platform made of poly(ethylene terephthalate) (PET) covered with a layer of indium tin oxide (ITO). This composite is subjected to dielectric barrier discharge (DBD) that develops the active surface of the PET/ITO foil. To enhance the Raman signal, a modified composite was covered with a thin layer of silver using the physical vapor deposition (PVD) technique. The SERS platform was used for measurements of para-mercaptobenzoic acid (p-MBA) and popular pesticides, i.e., Thiram and Carbaryl. The detection and identification of pesticides on the surface of fruits and vegetables is a crucial issue due to extensive use of those chemical substances for plant fungicide and insecticide protection. Therefore, the developed PET/ITO/Ag SERS platform was dedicated to quantitative analysis of selected pesticides, i.e., Thiram and Carbaryl from fruits. The presented SERS platform exhibits excellent enhancement and reproducibility of the Raman signal, which enables the trace analysis of these pesticides in the range up to their maximum residues limit. Based on the constructed calibration curves, the pesticide concentrations from the skin of apples was estimated as 2.5 µg/mL and 0.012 µg/mL for Thiram and Carbaryl, respectively. Additionally, the PET/ITO/Ag SERS platform satisfies other spectroscopic properties required for trace pesticide analysis e.g., ease, cost-effective method of preparation, and specially designed physical properties, especially flexibility and transparency, that broaden the sampling versatility to irregular surfaces.